This surge reflects not just increased interest but actual procedures being performed, with liposuction procedures up 7% and tummy tucks increasing by 5% year over year
(2021) "Once-weekly semaglutide in adults with overweight or obesity" The New England Journal of Medicine, 384(11) 3
Here, well be reviewing Cignas coverage for the GLP-1 agonists Ozempic (semaglutide), Wegovy (semaglutide), Mounjaro (tirzepatide), and Zepbound (tirzepatide), including whether prior authorization is needed for coverage and, if so, how to get it
No single agent is specifically indicated for cholesterol reduction, and choice should be based on licensed indications for diabetes or weight management
We recommend getting in touch if any side effect feels particularly severe or doesnt subside after a few hours
Its sold under the names Ozempic and Wegovy , but these arent identical products